Company Filing History:
Years Active: 2013
Title: The Innovative Contributions of Roaggai Sun
Introduction
Roaggai Sun is a notable inventor based in Ellicott City, MD (US). He has made significant strides in the field of medical research, particularly in the development of vaccines. His work focuses on combating tuberculosis, a disease that continues to pose a global health challenge.
Latest Patents
Roaggai Sun holds a patent for a recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease. This innovative vaccine comprises a recombinant Bacille Calmette-Guerin (BCG) subunit-based formulation. It overexpresses one or more Mtb antigens and Mtb resuscitation or reactivation antigens, while also up-regulating a portion of the DosR regulon. The vaccine is protective against active Mtb infection both pre- and post-exposure, effectively preventing disease symptoms due to the recurrence of a latent Mtb infection. He has 1 patent to his name.
Career Highlights
Roaggai Sun is associated with the Aeras Global Tuberculosis Vaccine Foundation, where he contributes his expertise to the development of innovative vaccine solutions. His work is crucial in the fight against tuberculosis, aiming to improve health outcomes for individuals at risk of this infectious disease.
Collaborations
Roaggai collaborates with esteemed colleagues such as Avigdor Shafferman and Anat Zvi. Their combined efforts in research and development enhance the potential for breakthroughs in vaccine technology.
Conclusion
Roaggai Sun's contributions to vaccine development, particularly in the fight against tuberculosis, highlight his commitment to improving public health. His innovative work continues to pave the way for advancements in medical science and disease prevention.